KP

Kannappan Pasupathy Padma Sushma

Active Director Director DIN 09042090
DIN 09042090 First appointment Jan 2021 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jan 2021
Shareholding value •••• Premium profile

About Kannappan Pasupathy Padma Sushma

Data last updated:

Kannappan Pasupathy Padma Sushma has 5 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Guduvanchery Pharmacy Private Limited and Deepam Eye Hospital Private Limited. Formerly with 1 company, such as Azotus Generic Salvage N Rejuvant Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹26.34 Cr; the largest is Guduvanchery Medic Centre Private Limited at ₹13.88 Cr (FY 2025).

DIN 09042090
Primary Designation Director
First Appointment 25 Jan 2021
Oldest Company Age 5 yrs
Largest company Guduvanchery Medic Centre Private Limited · ₹13.88 Cr (FY 2025)
Combined revenue ₹26.34 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director15 Nov 20252021₹13.88 Cr (FY 2025)Active
Director16 Jun 20222022₹6.81 Cr (FY 2025)Active
Deepam Eye Hospital Private Limited U85110TN2021PTC146515
Director14 Feb 20222021₹5.64 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jan 20212021₹4.4 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Guduvanchery Pharmacy Private Limited
Deepam Eye Hospital Private Limited
Guduvanchery Medic Centre Private Limited
Azotus Generic Salvage N Rejuvant Private Limited
Premium access

Shareholding and investment profile for Kannappan Pasupathy Padma Sushma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kannappan Pasupathy Padma Sushma

Kannappan Pasupathy Padma Sushma has 5 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Guduvanchery Pharmacy Private Limited and Deepam Eye Hospital Private Limited. Formerly with 1 company, such as Azotus Generic Salvage N Rejuvant Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹26.34 Cr; the largest is Guduvanchery Medic Centre Private Limited at ₹13.88 Cr (FY 2025).

Kannappan Pasupathy Padma Sushma is associated with 3 companies as Director and Additional Director, including Guduvanchery Medic Centre Private Limited (₹13.88 Cr), Guduvanchery Pharmacy Private Limited (₹6.81 Cr), Deepam Eye Hospital Private Limited (₹5.64 Cr).

Kannappan Pasupathy Padma Sushma has expertise in General Business.

Kannappan Pasupathy Padma Sushma has 5 years in corporate governance.

By reported revenue, the largest current company of Kannappan Pasupathy Padma Sushma is Guduvanchery Medic Centre Private Limited, with revenue of ₹13.88 Cr (FY 2025).

The 3 current companies of Kannappan Pasupathy Padma Sushma that report revenue have a combined latest revenue of ₹26.34 Cr.

Kannappan Pasupathy Padma Sushma currently holds positions at 3 companies: Guduvanchery Medic Centre Private Limited (₹13.88 Cr), Guduvanchery Pharmacy Private Limited (₹6.81 Cr), Deepam Eye Hospital Private Limited (₹5.64 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available